



	Questions : Lok Sabha




























Screen Reader Access
Skip to Main Content
Skip to Navigation



Text Size

                                A

                                A
A















हिन्दी मे








Parliament of India Lok Sabha House of the
                        People






* Special Characters not allowed












India Time 


Your Time 


                        Sunday,
                        10 April 2022









HomeMembersSitting MembersMembers Home PageMembers' PortalContact DetailsMembers SearchStatistical AnalysisAttendance of MembersHandbook Members Since 1952Digitized Who's WhoOthers BusinessProvisional CalendarList of BusinessPapers to be LaidList of Private Members' BusinessBulletin-IDigitized Lok Sabha Bulletin Part IBulletin-IIStatement of WorkSpecial Mentions (ZERO HOUR)Resume of WorkDigitized Resume of Work done by Lok Sabha QuestionsHomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions DebatesIntroductionSynopsisUncorrected DebateText of DebateDigitized DebatesConstituent Assembly DebatesWit And HumourDebate SearchHindi FontsDisclaimer Papers LaidPapers Laid on the Table of the House LegislationIntroduction(How Bill Becomes Act)Bills IntroducedBills PassedBills PendingBills AssentedBills LapsedBills WithdrawnBills NegativedBills Search Disclaimer CommitteesIntroductionChairpersonSummary of WorkCommittee Meetings ScheduleBills Referred to CommitteesReports PresentedDigitized ReportsPress ReleaseMembership SearchToday's Committee MeetingsCommittee Subject SelectedDepartment Related-RS Govt. AssurancesSANSAD TVIntranet





HomeQuestion ListStatus of notices of questionQuestions CalendarGrouping of Ministries - AlphabeticalOfficers in Min./Dept. Dealing with Parliamentary WorkQuestion SearchSupplementary Questions











Download as PDF




Print












PDF/WORD(Hindi)


PDF/WORD




                                    GOVERNMENT OF INDIA
                                





                                    MINISTRY OF
                                    CHEMICALS AND FERTILIZERS






                                    LOK SABHA
                                





UNSTARRED 


                                    QUESTION NO:
                                

5006






                                    ANSWERED ON: 
                                

23.07.2019






IDC for Research




Raksha Nikhil Khadse














                        Will the Minister of





CHEMICALS AND FERTILIZERS


                        be pleased to state:-















Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state: (a) whether the Government has constituted Inter-Departmental Committee (IDC) to coordinate research work in the area of pharmaceuticals undertaken by organisations & institutions of the Government to ensure economy, efficiency, effectiveness and transparency for developing India; (b) if so, the details thereof; (c) whether the Government is taking steps to establish world class research & development facilities in the country so as to make India the top most drug discovery & innovation hub in the world; and (d) if so, the details thereof?






ANSWER




MINISTER IN THE MINISTRY OF CHEMICALS AND FERTILIZERS(SHRI D.V. SADANANADA GOWDA)(a) & (b): Yes, Sir. The Department of Pharmaceuticals has constituted an Inter-Departmental Committee (IDC) to coordinate work in the area of Pharmaceuticals undertaken by organizations and institutes under the Central Government for institutionalizing a robust mechanism to ensure economy, efficiency, effectiveness and transparency in the arena of Pharmaceutical research. The Terms of Reference (ToR) of the Committee are: (i) To periodically review and coordinate the research work undertaken by various governmental organizations under different Central Ministries/Departments in a collaborative, synchronized and synergized way for optimum utilization of funds; and (ii) To ensure that research is conducted in such a way so as to avoid duplication of efforts and resources.(c):	Yes, Sir.(d) :   The details are given at Annexure.  AnnexureAnnexure referred to in part (d) of Lok Sabha Unstarred Question No. 5006 for reply on 23.07.2019 raised by SHRIMATI RAKSHA NIKHIL KHADSE regarding ‘IDC for Research’.  The details of various steps taken by the Government of India to establish pharmaceutical research and development facilities in the country are as following:-(i)	The Department of Pharmaceuticals has established seven National Institutes of Pharmaceutical Education & Research (NIPERs) at Mohali, Hyderabad, Ahmedabad, Guwahati, Kolkata, Raebareli and Hajipur respectively to promote basic and applied research catering to the needs of pharma industry. These NIPERs carry out research in the areas of New Drug Discovery and Drug Development in various therapeutic areas. These Institutes impart postgraduate and PhD education in various specializations of pharmaceuticals.(ii)	The Council of Scientific and Industrial Research(CSIR) supports drug research through state-of-the-art infrastructure and facilities at its constituent laboratories like CSIR-Central Drug Research Institute (CSIR-CDRI), CSIR-Indian Institute of Chemical Technology (CSIR-IICT), CSIR-Institute of Microbial Technology (CSIR-IMTECH), CSIR-Indian Institute of Toxicology Research, etc. The laboratories are pursuing drugs and pharmaceutical Research and Development activities with an emphasis on affordable healthcare.(iii)	The Department of Science and Technology (DST), under the Drugs and Pharmaceuticals Research Programme (DPRP), supports projects for creation of facilities where leading academic institutions/national laboratories having scientific expertise can cater to the needs of Pharma Industries. Under this programme, specialized structures like cold rooms, animal house isolation chambers, etc can be created.  Under this programme upto 2018-19, 55 state-of-the-art infrastructure facilities for Pharmaceutical Research and Development have been created in different premier institutions and Universities, including  Facilities for Bio-availability, Pharmacoinformatics, Regulatory Toxicology, Safety Pharmacology at NIPER, Mohali; Pharmacokinetic & Metabolic Studies, Regulatory Pharmacology & Toxicology, Medium Throughput Screening at CDRI, Lucknow; Transgenic & Gene Knockout Mice, Clinical Research facility to Stem Cell Technologies and regenerative medicine, Biosafety Laboratory at CCMB, Hyderabad and Bioequivalence, Pharmacovigilance, New Chemical Entities development, Animal Facilities for Indian Systems of Medicine in other Universities & Institutions.(iv)	To strengthen research facilities for drug development, the Indian Council of Medical Research (ICMR) has identified the Product Development Centres at PGIMER-Chandigarh, CDRI-Lucknow, Nizam Institute-Hyderabad, Seth G.S. Medical Collage & KEM Hospital-Mumbai and AIIMS-Delhi. These centres will evaluate potential products developed by ICMR funded projects in colleges/ICMR centres/centre for advance research. The centres will carry out clinical trials for developing national guidelines/programs, for new drugs e.g. phytopharmaceuticals.(v)	The Department of Biotechnology (DBT), towards strengthening the product development for Biopharmaceuticals, has initiated a Mission entitled: Industry-Academia Collaborative Mission for Accelerating Discovery Research to Early Development for Biopharmaceuticals – “Innovate in India (i3) Empowering biotech entrepreneurs & accelerating inclusive innovation”. The National Biopharma Mission approved by the Cabinet at a total cost of US$ 250 million for five years with 50% funding through World Bank loan is being implemented by Biotechnology Industry Research Assistance Council (BIRAC) - a Public Sector Undertaking of Department of Biotechnology (DBT). The Mission is focusing on development of (i)Vaccines for Pneumococcus, Dengue, HPV and candidates for other diseases of high burden in India (ii) Biosimilars for cancer, diabetics and rheumatoid arthritis and (iii) Medical devices and diagnostics (iv)Process Development Laboratory; Chemistry, Manufacturing, Control Units and cGLP validation facility for Bio therapeutics.*****
























HomeArchiveIndex to Select Questions (1984-1999)Ballot ListStatistical Statements Relating to QuestionsUploading of Questions - Status QueryProcedure for Sending Text of Questions & AnswersDemarcation of responsibilities in Govt. of IndiaBrochure on Statutory Corporations, Companies and Other Bodies in Which the Government of India have financial or controlling interestHighlights pertaining to questions of 17th Lok Sabha






Contact Us 
Disclaimer











        Developed and Hosted by National Informatics Centre (NIC)

Content on this website is published,
            managed & maintained by Software Unit, Computer (HW & SW) Management. Branch,
            Lok Sabha Secretariat





HomeMembersBusinessQuestionsDebatesPapers Laid


LegislationCommitteesSANSAD TVIntranetSecretariatPRIDE


RecruitmentSC/ST ReservationConferenceParliament Library


About ParliamentPhoto GalleryRelated LinksRTITendersFAQ


SpeakerDy. SpeakerLeader of the HousePanel of ChairpersonsContact UsFeedback


Council of MinistersPublications of MinistriesParliamentry ProceduresJournal of Parliamentary Information
Visitor's Counter:113105801







Copyright
Privacy Policy
Disclaimer
Terms &
                Conditions

                Accessibility Statement
Accessibility
                Options
Feedback
Site Map







